Sumitomo Mitsui Trust Holdings Inc. Purchases 6,250 Shares of Humana Inc. (HUM)
Sumitomo Mitsui Trust Holdings Inc. increased its position in Humana Inc. (NYSE:HUM) by 1.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 438,594 shares of the insurance provider’s stock after buying an additional 6,250 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned 0.30% of Humana worth $106,855,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale increased its stake in shares of Humana by 1.9% in the third quarter. DekaBank Deutsche Girozentrale now owns 54,192 shares of the insurance provider’s stock valued at $13,560,000 after buying an additional 1,023 shares during the period. Rhumbline Advisers increased its stake in shares of Humana by 3.5% in the third quarter. Rhumbline Advisers now owns 259,908 shares of the insurance provider’s stock valued at $63,321,000 after buying an additional 8,827 shares during the period. Todd Asset Management LLC acquired a new position in shares of Humana in the third quarter valued at approximately $501,000. Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of Humana by 613.6% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 26,340 shares of the insurance provider’s stock valued at $6,417,000 after buying an additional 22,649 shares during the period. Finally, Providence First Trust Co acquired a new position in shares of Humana in the third quarter valued at approximately $1,124,000. 96.15% of the stock is owned by institutional investors.
Several research firms have recently issued reports on HUM. BMO Capital Markets upped their price objective on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $242.00 price objective (down previously from $245.00) on shares of Humana in a research note on Thursday, November 9th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $260.00 price objective (up previously from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Deutsche Bank AG upped their price objective on Humana from $234.00 to $243.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Finally, Oppenheimer Holdings, Inc. increased their target price on shares of Humana from $236.00 to $255.00 and gave the company an “outperform” rating in a research report on Thursday, August 3rd. Thirteen analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Humana presently has an average rating of “Hold” and a consensus price target of $252.81.
Shares of Humana Inc. (HUM) traded down $6.28 on Thursday, hitting $233.28. The company had a trading volume of 1,618,700 shares, compared to its average volume of 1,380,572. Humana Inc. has a 12 month low of $186.25 and a 12 month high of $264.56. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. The company has a market cap of $34,223.56, a PE ratio of 20.44, a P/E/G ratio of 1.65 and a beta of 0.91.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The company had revenue of $13.28 billion for the quarter, compared to analysts’ expectations of $13.41 billion. During the same period last year, the business earned $3.18 EPS. Humana’s quarterly revenue was down 3.0% compared to the same quarter last year. analysts anticipate that Humana Inc. will post 11.63 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is currently 12.59%.
In related news, insider William Kevin Fleming sold 3,071 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the transaction, the insider now directly owns 7,681 shares in the company, valued at approximately $1,927,777.38. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Timothy S. Huval sold 7,803 shares of the stock in a transaction on Friday, September 1st. The stock was sold at an average price of $258.14, for a total value of $2,014,266.42. Following the completion of the transaction, the vice president now owns 8,831 shares in the company, valued at $2,279,634.34. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,660 shares of company stock worth $5,319,600. 0.80% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/11/16/sumitomo-mitsui-trust-holdings-inc-purchases-6250-shares-of-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.